Secor Capital Advisors’s Acorda Therapeutics ACOR Stock Holding History

Secor Capital Advisors’s Portfolio ACOR Stock Details ACOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-106	Closed	-$198K	–	606
2018 Q4	$198K	Buy	+106	New	+$231K	0.03%	418
2017 Q3	–	Sell	-176	Closed	-$417K	–	568
2017 Q2	$417K	Buy	+176	New	+$349K	0.04%	367
2016 Q4	–	Sell	-110	Closed	-$274K	–	648
2016 Q3	$274K	Buy	+110	New	+$328K	0.03%	440
2016 Q2	–	Sell	-346	Closed	-$1.1M	–	739
2016 Q1	$1.1M	Buy	+346	New	+$1.44M	0.15%	140
2015 Q2	–	Sell	-58	Closed	-$231K	–	577
2015 Q1	$231K	Buy	+58	New	+$266K	0.09%	366
2014 Q3	–	Sell	-116	Closed	-$471K	–	392
2014 Q2	$471K	Buy	+116	New	+$473K	0.25%	143
2014 Q1	–	Sell	-179	Closed	-$628K	–	405
2013 Q4	$628K	Buy	+179	New	+$698K	0.25%	171

Other funds holding ACOR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Secor Capital Advisors's ACOR Position: Q1 2019 in Review

Secor Capital Advisors sold out of Acorda Therapeutics (ACOR) in Q1 2019, closing a stake of 106 shares — an estimated $198K sold.

Secor Capital Advisors first reported a position in ACOR in Q4 2013 and held it in 7 quarters. The position peaked at $1.1M in Q1 2016. 184 funds tracked by Wall St. Rank hold ACOR as of Q1 2019.

Secor Capital Advisors reported no remaining Acorda Therapeutics position as of Q1 2019 after selling out during the quarter.
Secor Capital Advisors sold 106 Acorda Therapeutics shares in Q1 2019, an estimated $198K.
Secor Capital Advisors first reported a position in Acorda Therapeutics in Q4 2013 and held it in 7 quarters.
Secor Capital Advisors's Acorda Therapeutics position peaked at $1.1M in Q1 2016.
184 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q1 2019.

Based on Secor Capital Advisors's 13F filing for Q1 2019, filed 15 May 2019.